Christopher Suciu, M.D., M.S.

ASSISTANT PROFESSOR OF PATHOLOGY, OHSU

ASSOCIATE DIRECTOR, KNIGHT DIAGNOSTIC LABORATORES, OREGON HEALTH & SCIENCE UNIVERSITY

Biographical Sketch

Dr. Suciu received an M.D. and M.S. from Tulane University. He completed residency at UPMC (University of Pittsburgh), followed by blended fellowships in molecular pathology and clinical informatics at Washington University in St. Louis. He is board-certified in Anatomic Pathology, Clinical Pathology, Molecular Genetic Pathology, and Clinical Informatics.

Dr. Suciu is interested in implementing genomic assays for the identification of diagnostic, prognostic, and therapeutic biomarkers, and in the integration and use of genomic data in electronic health records.

 

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More